PS(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
|
Basic information |
| Metabolite name | PS(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) |
 | HMDB0010167 |
 |
C02737 |
 |
24779546 |
| Synonyms | NA |
| No. of studies | 4 |
|
Basic information |
| Metabolite name | PS(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) |
| HMDB0010167 |
|
C02737 |
|
24779546 |
| Synonyms | NA |
| No. of studies | 4 |
|
Relationship between PS(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) and depression (count: 4) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1098 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M1098 | Type2 | CUMS + L-theanine group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M1098 | Type2 | CUMS + fluoxetine group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M117 | Type1 | CVS group vs. control group | Faece | Wistar rat | Up |
| Study M609 | Type1 | LPS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M609 | Type2 | LPS + NBP group vs. LPS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M677 | Type1 | CVS group vs. control group | Faece | Wistar rat | Up |
| Study M677 | Type2 | CVS + Chaihu-Shu-Gan-San group vs. CVS group | Faece | Wistar rat | Down |
| Study M677 | Type2 | CVS + fluoxetine group vs. CVS group | Faece | Wistar rat | Up |